Pilot study of patient satisfaction with nonfluorinated topical steroids compared with a topical immunomodulator in atopiform dermatitis

International Journal of Dermatology

Volumn 43, Issue 3, 2004, Pages 215-219

  Burkhart, Craig N ^a,b   Burkhart, Craig G ^a  

^a BROWN UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE BUTYRATE; LOCOID LIPOCREAM; PROTOPIC OINTMENT; TACROLIMUS; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG PREFERENCE; DRUG WITHDRAWAL; HUMAN; PATIENT SATISFACTION; PILOT STUDY; PRESCRIPTION; QUESTIONNAIRE; RATING SCALE; SCHOOL CHILD; SIDE EFFECT; SKIN PROTECTION;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; CHILD; DERMATITIS, ATOPIC; FEMALE; HUMANS; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PILOT PROJECTS; QUESTIONNAIRES; TACROLIMUS; TREATMENT OUTCOME;

EID: 1842487414     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02118.x     Document Type: Article

References (22)

1. Burkhart CN, Gottwald L, Nelson L. Tacrolimus and pimecrolimus: Revolutionary new topical immunomodulators for skin disorders. J Int Pediatrics 2002, in press.
2. Morris RE. Mechanisms of action of new immunosuppressive drugs. Kidney Int 1996; 49 (Suppl. 53): 26-38.
3. Kawashima H, Nakagawa H, Ohtsuki M, et al. Tacrolimus concentration in blood during topical treatment of atopic dermatitis. Lancet 1996; 348: 1240-1241.
4. Johnson WR (ed.). On Cutaneous Diseases. London: London Press, 1808.
5. Von Hebra H. Dermatomycosis Diffusa Flexorum, in die Krankhaften Veranderungen der Haut und Ihrer Anhangsgebilde Mit Ihrer Beziehungen Zu der Krankheiten Des Gesamtorganismus. Braunschweig: Wreden, 1884.
6. Hill LW. Evolution of atopic dermatitis. Arch Dermatol 1935; 32: 451-456.
7. Verboom P, Hakkaart-Van Roijen L, Sturkenboom M, et al. The cost of atopic dermatitis in the Netherlands: An international comparison. Br J Dermatol 2002; 147: 716-724.
8. Bleiker TO, Shahidullah H, Dutton E, Graham-Brown RAC. The prevalence and incidence of atopic dermatitis in a birth cohort: The importance of a family history of atopy. Arch Dermatol 2000; 136: 274-279.
9. Falade AG, Olawuyi F, Osinusi K, Onadeko BO. Prevalence and severity of symptoms of asthma, allergic rhino-conjunctivitis and atopic eczema in secondary school children in Ibadan, Nigeria. East Afr Med J 1998; 75: 695-698.
10. Burkhart CG. Contact irritant dermatitis and anti-pruritic agents: The need to address the itch. J Drugs Dermatol 2003; 2: 143-146.
11. Smith HR, Basketter DA, McFadden JP. Irritant dermatitis, irritancy and its role in allergic dermatitis. Clin Exp Dermatol 2002; 27: 138-146.
12. Bos JD. Atopiform dermatitis. Br J Dermatol 2002; 147: 426-429.
13. Sakuma S, Higashi Y, Sato N, et al. Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system (comparison with steroids). Int Immunopharmacol 2001; 1: 1219-1226.
14. Walter IB, Ozawa M, Cardinale I, et al. Narrowband (312-nm) suppresses interferon γ and interleukin-12 and increases interleukin-4 transcripts. Arch Dermatol 2003; 139: 155-161.
15. 28-stimulated T cells from patients with atopic dermatitis. J Invest Dermatol 2001; 117: 1635-1646.
16. FK 506 Ointment Study Group. A late phase II study to determine the concentration of FK 506 (tacrolimus) ointment in atopic dermatitis (Part 1). Revised version [in Japanese]. Nishinihon J Dermatol 1998; 60: 685-698.
17. FK 506 Ointment Study Group. Phase III comparative study of FK 506 ointment vs betamethasone valerate ointment in atopic dermatitis (trunk/extremities) [in Japanese]. Nishinhon J Dermatol 1997; 59: 870-879.
18. FK 506 Ointment Study Group. Phase III comparative study of FK 506 ointment vs alclometasone dipropionate ointment in atopic dermatitis (face and neck) [in Japanese]. Acta Dermatol (Kyoto) 1997; 92: 277-288.
19. Nakagawa H. Comparative study of FK 506 (tacrolimus) ointment vs. alclometasone dipropionate ointment in atopic dermatitis (face and neck lesions) [abstract 1266]. J Invest Dermatol 1998; 119: 683.
20. Luger T, Van Leent EJM, Graeber M. SDZ ASM 981: An emerging safe and effective treatment for atopic dermatits. Br J Dermatol 2001; 144: 788-794.
21. Baron ED, Barzilai D, Johnston G, et al. Atopic dermatitis management: Comparing the treatment patterns of dermatologists in Japan, USA, and UK. Br J Dermatol 2002; 147: 710-715.
22. Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia inpatients with atopic eczema. Br J Dermatol 2000; 142: 931-936.